KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old targetMarta Román, Ignacio Gil‐Bazo, Inés López et al.|Molecular Cancer|2018Cited by 306
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesotheliomaElisabet Aliagas, Ernest Nadal|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1